Gastric cancer in young patients: clinical and endoscopic features
https://doi.org/10.31146/2415-7813-endo-67-3-67-73
Abstract
About the Authors
M. A. ParonyanRussian Federation
S. S. Pirogov
Russian Federation
V. I. Ryabtseva
Russian Federation
G. F. Minibaeva
Russian Federation
D. G. Sukhin
Russian Federation
V. M. Khomyakov
Russian Federation
I. V. Kolobaev
Russian Federation
A. B. Ryabov
Russian Federation
V. S. Surkova
Russian Federation
A. D. Kaprin
Russian Federation
References
1. [Malignant neoplasms in Russia in 2023 (incidence and mortality)] / eds by A.D. Kaprin et al. - Moscow: P.A. Herzen Moscow Oncology Research Institute - branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation Publ., 2024. 276 p.: ill. (in Russ.)@@ Злокачественные новообразования в России в 2023 году (заболеваемость и смертность) / под редакцией А.Д. Каприна [и др.]. - Москва: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. - 276 с.: ил.
2. Cheng L., Chen S., Wu W. et al. Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis. J Cancer Res Clin Oncol. 2020 Nov;146(11):2937-2947. doi: 10.1007/s00432-020-03268-w.
3. Kono Y., Kanzaki H., Iwamuro M., Kawano S., Kawahara Y., Okada H. Reality of Gastric Cancer in Young Patients: The Importance and Difficulty of the Early Diagnosis, Prevention and Treatment. Acta Med Okayama. 2020 Dec;74(6):461-466. doi: 10.18926/AMO/61204.
4. Park K.B., Jun K.H. Clinicopathological Features and Prognosis of Gastric Cancer in Young Patients. J Minim Invasive Surg. 2020 Dec 15;23(4):161-162. doi: 10.7602/jmis.2020.23.4.161.
5. van der Sluis L., van Dieren J.M., van der Post R.S., Bisseling T.M. Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review. Hered Cancer Clin Pract. 2024 Oct 8;22(1):21. doi: 10.1186/s13053-024-00293-5.
6. Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis. 2012 Jan;13(1):2-9. doi: 10.1111/j.1751-2980.2011.00550.x.
7. Derks S., Liao X., Chiaravalli A.M. et al. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers. Oncotarget. 2016 May 31;7(22):32925-32. doi: 10.18632/oncotarget.9076.
8. Cristescu R., Lee J., Nebozhyn M. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015 May;21(5):449-56. doi: 10.1038/nm.3850.
9. Shibata D., Hawes D., Stemmermann G.N., Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):213-7. PMID: 8391356.
10. Kim W., Youn S., Won Y. et al. Clinicopathologic Characteristics of Young Gastric Cancer Patients: Diagnostic Staging Accuracy and Survival. J Minim Invasive Surg. 2020 Dec 15;23(4):163-171. doi: 10.7602/jmis.2020.23.4.163.
11. Borrmann R. Geschwulste Des Magens und Des Duodenums. In: Henke F, Lubarsch O (eds) Handbuch der speziellen patholog- ichen anatomie und histologic. Vol. IV/I. Berlin: Springer, 1986; pp. 812-1054.
12. Song X.H., Zhang W.H., Kai-Liu, Chen X.L., Zhao L.Y., Chen X.Z., Kun-Yang, Zhou Z.G., Hu J.K. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. World J Surg Oncol. 2020 Aug 13;18(1):204. doi: 10.1186/s12957-020-01987-5.
Review
For citations:
Paronyan M.A., Pirogov S.S., Ryabtseva V.I., Minibaeva G.F., Sukhin D.G., Khomyakov V.M., Kolobaev I.V., Ryabov A.B., Surkova V.S., Kaprin A.D. Gastric cancer in young patients: clinical and endoscopic features. Filin’s Clinical endoscopy. 2025;67(3):67-73. (In Russ.) https://doi.org/10.31146/2415-7813-endo-67-3-67-73


